Clinical Trial Update: Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the ENCHASE study evaluating edoxaban to correct cancer-related coagulopathy in patients with active cancer and acute ischemic stroke;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cancer-associated Coagulopathy
• Stroke

Drugs mentioned

• Savaysa (edoxaban)

Snippet

Sponsor: Samsung Medical Center | Conditions: Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban) | Phase 2, Phase 3 | Status: UNKNOWN